World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT03058263
Date of registration: 12/02/2017
Prospective Registration: No
Primary sponsor: Indonesia University
Public title: Effect of Neostigmine on the Recovery of Rocuronium: A Comparison Between Partial and TOF Ratio-Based Dose
Scientific title: The Effectiveness of Neostigmine on the Recovery of Rocuronium-Induced Neuromuscular Blockade: A Comparison Between Partial Dose and TOF Ratio-Based Adjustment Dose
Date of first enrolment: October 2016
Target sample size: 66
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03058263
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: None (Open Label).  
Phase:  Phase 1/Phase 2
Countries of recruitment
Indonesia
Contacts
Name:     Arif HM Marsaban, Consultant
Address: 
Telephone:
Email:
Affiliation:  Indonesia University
Key inclusion & exclusion criteria

Inclusion Criteria:

- patients aged 18-60 years old

- American Society of Anesthesiologists (ASA) physical status I-II who were planned to
undergo any elective surgery at operating room in general anesthesia

- subjects had been explained about the study, and agreed to enroll and have signed the
informed consent form

Exclusion Criteria:

- BMI = 30

- had any severe kidney or liver disease

- had neuromuscular disease or asthma

Drop out Criteria:

- Duration of operation less than one hour or more than 2 hours

- during surgery received maintenance dose of neuromuscular block

- intraoperative cardiac arrest was occurred



Age minimum: 18 Years
Age maximum: 60 Years
Gender: All
Health Condition(s) or Problem(s) studied
General Anesthesia
Muscle Relaxant
Intervention(s)
Drug: Dose of Neostigmine
Primary Outcome(s)
time needed to reach TOF ratio = 90% in group with partial dose of neostigmine [Time Frame: Day 1]
TOF ratio between partial dose of neostigmine and TOF ratio-based dose of neostigmine [Time Frame: Day 1]
TOF ratio with TOF ratio-based dose of neostigmine [Time Frame: Day 1]
TOF ratio with partial dose of neostigmine [Time Frame: Day 1]
Secondary Outcome(s)
Secondary ID(s)
IndonesiaUAnes011
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history